The store will not work correctly when cookies are disabled.
4,5-Dihydro-6-phenyl-4-p-tolyl-2H-indazol-3-ol
ID: ALA2272756
PubChem CID: 76312604
Max Phase: Preclinical
Molecular Formula: C20H18N2O
Molecular Weight: 302.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C2CC(c3ccccc3)=Cc3n[nH]c(O)c32)cc1
Standard InChI: InChI=1S/C20H18N2O/c1-13-7-9-15(10-8-13)17-11-16(14-5-3-2-4-6-14)12-18-19(17)20(23)22-21-18/h2-10,12,17H,11H2,1H3,(H2,21,22,23)
Standard InChI Key: ULMKRNZKXWBCOA-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
33.7388 -6.2966 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5068 -6.0014 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.0260 -6.6376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5745 -7.3293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7918 -8.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2093 -8.7033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4178 -8.4902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2046 -7.6987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7871 -7.1162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8456 -6.5934 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.5874 -8.3299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1616 -7.7556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1704 -8.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7964 -9.1255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9573 -7.9647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5879 -9.3428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9661 -8.9693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8353 -9.0685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0484 -9.8600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4659 -10.4425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6744 -10.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4654 -9.4379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0438 -8.8595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
1 9 2 0
4 9 1 0
3 10 1 0
11 12 1 0
11 14 2 0
12 15 2 0
13 15 1 0
13 16 2 0
14 16 1 0
13 17 1 0
5 11 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
18 23 2 0
7 18 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 302.38 | Molecular Weight (Monoisotopic): 302.1419 | AlogP: 4.50 | #Rotatable Bonds: 2 |
Polar Surface Area: 48.91 | Molecular Species: ACID | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.22 | CX Basic pKa: 2.80 | CX LogP: 4.58 | CX LogD: 3.18 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.73 | Np Likeness Score: -0.08 |
References
1. Shakil NA, Singh MK, Sathiyendiran M, Kumar J, Padaria JC.. (2013) Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives., 59 [PMID:23229055] [10.1016/j.ejmech.2012.10.038] |